(Q58862259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

acute myeloid leukemia

0 references

author

Angela Nebbioso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Emmanuelle Germain

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Paola Bontempo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Alessandro Weisz

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Hinrich Gronemeyer

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Lucia Altucci

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

5

Concetta Ambrosino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

9

Felicetto Ferrara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

12

Angel R de Lera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

2

Nicole Clarke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Emilie Voltz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Rosana Alvarez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Ettore M Schiavone

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Francesco Bresciani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

26 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

77-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm1161

6 January 2020

exact match

0 references

cites work

Histone deacetylases and cancer: causes and therapies

1 reference

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

21 January 2018

1 reference

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17).

21 January 2018

1 reference

Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives

21 January 2018

1 reference

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines

21 January 2018

1 reference

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo

21 January 2018

1 reference

Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL

21 January 2018

1 reference

Acetylated sp3 is a transcriptional activator

21 January 2018

1 reference

Regulation of the activity of Sp1-related transcription factors.

21 January 2018

1 reference

Transcription factor Sp3 is regulated by acetylation

21 January 2018

1 reference

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

The promise of retinoids to fight against cancer.

21 January 2018

1 reference

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.

21 January 2018

1 reference

Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway

21 January 2018

1 reference

Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.

21 January 2018

1 reference

Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells

21 January 2018

1 reference

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

Targeted histone deacetylase inhibition for cancer therapy

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Targeting death receptors in cancer with Apo2L/TRAIL.

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM1161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619633%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference